HK1061686A1 - Method of manufacturing substance gm-95 - Google Patents

Method of manufacturing substance gm-95

Info

Publication number
HK1061686A1
HK1061686A1 HK04104674A HK04104674A HK1061686A1 HK 1061686 A1 HK1061686 A1 HK 1061686A1 HK 04104674 A HK04104674 A HK 04104674A HK 04104674 A HK04104674 A HK 04104674A HK 1061686 A1 HK1061686 A1 HK 1061686A1
Authority
HK
Hong Kong
Prior art keywords
group
general formula
thiol
produced
forming
Prior art date
Application number
HK04104674A
Other languages
English (en)
Inventor
Shozo Yamada
Kazuhiko Shigeno
Kazuhiro Kitagawa
Shigeo Okajima
Tetsuji Asao
Original Assignee
Sosei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Co Ltd filed Critical Sosei Co Ltd
Publication of HK1061686A1 publication Critical patent/HK1061686A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK04104674A 2000-12-12 2004-06-30 Method of manufacturing substance gm-95 HK1061686A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000377167 2000-12-12
PCT/JP2001/010870 WO2002048153A1 (fr) 2000-12-12 2001-12-12 Procede de preparation d'une substance gm-95

Publications (1)

Publication Number Publication Date
HK1061686A1 true HK1061686A1 (en) 2004-09-30

Family

ID=18845932

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104674A HK1061686A1 (en) 2000-12-12 2004-06-30 Method of manufacturing substance gm-95

Country Status (13)

Country Link
US (1) US6818764B2 (xx)
EP (1) EP1350794B1 (xx)
JP (1) JP4006589B2 (xx)
KR (1) KR100537595B1 (xx)
CN (1) CN1253458C (xx)
AT (1) ATE298342T1 (xx)
AU (2) AU2260402A (xx)
CA (1) CA2436942C (xx)
DE (1) DE60111651T2 (xx)
ES (1) ES2240336T3 (xx)
HK (1) HK1061686A1 (xx)
PT (1) PT1350794E (xx)
WO (1) WO2002048153A1 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9755592B2 (en) 2012-06-14 2017-09-05 Skyworks Solutions, Inc. Power amplifier modules including tantalum nitride terminated through wafer via and related systems, devices, and methods

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2517850A1 (en) * 2003-03-04 2004-09-16 Sosei Co., Ltd. Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
JP4876220B2 (ja) * 2005-05-13 2012-02-15 国立大学法人東京農工大学 テロメスタチン誘導体
US8093235B2 (en) * 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
WO2009018551A2 (en) * 2007-08-02 2009-02-05 Rutgers, The State University Of New Jersey Therapeutic compounds
JP5325882B2 (ja) * 2007-08-02 2013-10-23 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー 治療用化合物
US8796300B2 (en) 2009-11-05 2014-08-05 Rutgers, The State University Of New Jersey Therapeutic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1123937B1 (en) 1998-10-23 2004-05-26 Sosei Co., Ltd. Substance gm-95, process for producing the same and utilization thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9755592B2 (en) 2012-06-14 2017-09-05 Skyworks Solutions, Inc. Power amplifier modules including tantalum nitride terminated through wafer via and related systems, devices, and methods

Also Published As

Publication number Publication date
US6818764B2 (en) 2004-11-16
CN1253458C (zh) 2006-04-26
JP4006589B2 (ja) 2007-11-14
EP1350794B1 (en) 2005-06-22
JPWO2002048153A1 (ja) 2004-04-15
US20040049029A1 (en) 2004-03-11
DE60111651D1 (de) 2005-07-28
WO2002048153A1 (fr) 2002-06-20
AU2002222604B2 (en) 2006-06-08
DE60111651T2 (de) 2006-05-18
AU2260402A (en) 2002-06-24
ATE298342T1 (de) 2005-07-15
CA2436942A1 (en) 2002-06-20
EP1350794A1 (en) 2003-10-08
CN1479742A (zh) 2004-03-03
PT1350794E (pt) 2005-09-30
CA2436942C (en) 2008-07-22
EP1350794A4 (en) 2004-12-22
KR100537595B1 (ko) 2005-12-19
ES2240336T3 (es) 2005-10-16
KR20040014437A (ko) 2004-02-14

Similar Documents

Publication Publication Date Title
HUP0102843A2 (hu) Eljárás (3-izoxazolinil)-acil-benzolok előállítására
ATE264295T1 (de) 7-substituierte kondensierte ring-tetrazyclin- verbindungen
DK0758335T3 (da) Fremstilling af et camptothecinderivat ved intramolekylær ringslutning
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
WO2003014110A1 (fr) Derive de benzazepine, son procede de preparation et d'utilisation
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
LU91339I2 (fr) Darunavir ou un sel, ester ou promédicament pharmaceutiquement acceptable de celui-ci (prezista)
HK1056876A1 (en) Ethylenedianme derivatives
EP1206946A4 (en) MEDICAL SUBSTANCES AND PROCESS FOR OBTAINING THEM
FI960280A (fi) Uusi fuusioitunut indaanijohdannainen ja sen farmaseuttisesti hyväksyttävä suola
HK1061686A1 (en) Method of manufacturing substance gm-95
ES2157199T3 (es) Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento.
DK0597423T3 (da) Azetidinonforbindelse og fremgangsmåde til fremstilling deraf
DK0626377T3 (da) Fremgangsmåde til fremstilling af benzylidenderivater
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
EP1216988A4 (en) THIOALKYLAMINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE60014374D1 (de) Taxan-derivate und verfahren zu ihrer herstellung
ES2146661T3 (es) Nuevos derivados de cefem.
CA2380864A1 (en) Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
EP0785191A4 (en) INDANE FUSION DERIVATIVES AND THEIR SALTS
WO2001007439A3 (en) Process for the production of epothiolone b and derivatives as well as intermediate products for this process
UA66930C2 (uk) Похідні 4'-демікарозил-8а-аза-8а-гомотилозину
NO20030640L (no) Fremgangsmåte for fremstilling av bicykliske forbindelser og mellomprodukter derfor
WO2002020531A3 (de) Verfahren zur herstellung anellierter tetrahydro-[1h]-triazole

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091212